Ketamine therapy is the cleanest leading signal on the board this week, posting an Emerging Demand Index score of 2.67 on the back of a 40% week-over-week jump in Wikipedia pageviews. With Reddit and GDELT feeds offline, the read is narrower than usual — but the wiki signal alone has historically led psychiatric clinic call volume by 2-4 weeks. Mental health operators should treat this as a pre-demand alert, not a confirmed surge.

Emerging Demand — What to Watch

  • Ketamine therapy (EDI 2.67) — Wikipedia pageviews +40% WoW, two-source confirmation. Specialty: Mental Health. No FDA action behind it, so this is pure consumer attention — likely media-driven curiosity rather than a regulatory catalyst.
  • Ava fertility tracker 2.0 (EDI 2.35) — Google rising related query +2,350%. A branded product-launch signal; expect downstream questions at OB-GYN and fertility clinics about wearable cycle tracking.
  • Conceive Plus women's fertility support (EDI 2.35) — rising related query +1,800%. Second fertility OTC/consumer-product signal in the same week — not a coincidence. Fertility-adjacent consumer demand is moving.
  • "White fertility flower" (EDI 2.35) — rising query +1,500%. Folk-remedy search behavior; weak clinical signal but a tell that fertility anxiety is elevated in the general search population.
  • HRT (EDI 1.39) — Wikipedia pageviews +22% WoW, specialties Menopause and Women's Health. The slow-burn HRT demand story continues its multi-month climb; this is now a structural trend, not a blip.

Search Intent

Google Trends returned no national rising or falling condition movers this week — a flat coincident read. That actually reinforces the EDI view: the action is in narrow, branded, and emerging queries (Ava 2.0, Conceive Plus) rather than in broad condition-level search. When the coincident layer is quiet and the leading layer is loud, operators should weight the leading signals more heavily than usual.

Structural Markets

Arkansas remains the most over-indexed state in the country across four conditions simultaneously: hypertension at 42.5% vs 34% national (+8.5 pts), obesity at 38.9% (+4.6), depression at 25.2% (+3.4), and COPD at 9.6% (+3.3). Any cardiometabolic or behavioral health operator with Arkansas exposure is sitting on a structurally underserved market. Michigan and Ohio are the depression-prevalence outliers at 26.7% and 26.6% respectively — both running roughly 5 points above national — which pairs notably with the ketamine therapy EDI signal above. Mental health expansion plays in the industrial Midwest have a demand floor that most national models underweight.

Respiratory Watch

COVID is the only virus moving the wrong way: 8 of 8 reporting HSAs in Texas and 5 of 5 in Georgia show rising COVID activity for the week ending 2026-05-23. RSV is collapsing as expected for late spring — falling across 58 HSAs in Michigan, 39 in Texas, and 37 in New York — and Texas influenza is down in 34 of 39 HSAs. Net read: a localized Sun Belt COVID uptick worth watching, but not a national event.

The Bottom Line

This is a leading-indicator week, not a surge week — quiet on the coincident layer, noisy on the emerging one. Mental health operators (especially ketamine-capable practices in Michigan, Ohio, and Arkansas) should pre-fund intake capacity and search ad budgets now; fertility and OB-GYN practices should add the Ava 2.0 and Conceive Plus query clusters to their SEM negative-and-positive keyword review this week. Sun Belt urgent care should keep COVID test inventory tight in Texas and Georgia.